Anatomical Therapeutic Chemical (ATC) Classification

[ Brite menu | Download htext | Download json | Help ]
Search

1st Level  2nd Level  3rd Level  4th Level  5th Level  6th Level 

 A ALIMENTARY TRACT AND METABOLISM
 
 B BLOOD AND BLOOD FORMING ORGANS
 
 C CARDIOVASCULAR SYSTEM
 
 D DERMATOLOGICALS
 
 G GENITO URINARY SYSTEM AND SEX HORMONES
 
 H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS
 
 J ANTIINFECTIVES FOR SYSTEMIC USE
 
 L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
   L01 ANTINEOPLASTIC AGENTS
   L02 ENDOCRINE THERAPY
   L03 IMMUNOSTIMULANTS
   L04 IMMUNOSUPPRESSANTS
     L04A IMMUNOSUPPRESSANTS
       L04AA Selective immunosuppressants
       L04AB Tumor necrosis factor alpha (TNF-alpha) inhibitors [DG:DG01936]
       L04AC Interleukin inhibitors [DG:DG02019]
       L04AD Calcineurin inhibitors [DG:DG03129]
       L04AE Sphingosine-1-phosphate (S1P) receptor modulators
       L04AF Janus-associated kinase (JAK) inhibitors
         L04AF01 Tofacitinib [DG:DG00742]
           D09970  Tofacitinib (USAN)
           D09783  Tofacitinib citrate (JAN/USAN) <JP/US>
         L04AF02 Baricitinib
         L04AF03 Upadacitinib [DG:DG02829]
         L04AF04 Filgotinib [DG:DG01991]
         L04AF05 Itacitinib [DG:DG02833]
         L04AF06 Peficitinib [DG:DG01853]
         L04AF07 Deucravacitinib
         L04AF08 Ritlecitinib
       L04AG Monoclonal antibodies
       L04AH Mammalian target of rapamycin (mTOR) kinase inhibitors
       L04AJ Complement inhibitors
       L04AK Dihydroorotate dehydrogenase (DHODH) inhibitors
       L04AX Other immunosuppressants
 
 M MUSCULO-SKELETAL SYSTEM
 
 N NERVOUS SYSTEM
 
 P ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS
 
 R RESPIRATORY SYSTEM
 
 S SENSORY ORGANS
 
 V VARIOUS

[ DRUG | BRITE | KEGG2 | KEGG ]
Last updated: March 6, 2024
According to WHO's ATC 2024

» Japanese version